Telegraph Hill Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9

- Investments
-
75
- Portfolio
-
18
- Exits
-
31

Telegraph Hill Partners General Information
Description
Founded in 2001, Telegraph Hill Partners is a venture capital firm based in San Francisco, California. The firm prefers to invest in healthcare and life sciences sectors.
Contact Information
Website
www.thpartners.net
Year Founded
2001
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
PE/Buyout
Primary Office
- 300 Montgomery Street
- Suite 1130
- San Francisco, CA 94104
- United States
+1 (415) 000-0000
Telegraph Hill Partners Investments (75)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Cell Microsystems | 28-Aug-2023 | Later Stage VC | 00.00 | Discovery Tools (Healthcare) | Generating Revenue | 000 000000 |
GrayHawk Health | 09-May-2023 | 00000 00000 | 000.00 | Elder and Disabled Care | Generating Revenue | |
Panome Bio | 24-Feb-2023 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | 000 000000 |
Argonaut Manufacturing Services | 10-Jan-2023 | 00000 00000 | Other Commercial Services | Generating Revenue | 00000 00000000 00.0 | |
Mosaic Biosciences | 06-Jan-2023 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 00000000 00.0 |
Cell Microsystems | 15-Nov-2021 | 00000 00000 | 000.00 | Discovery Tools (Healthcare) | Generating Revenue | 000 000000 |
Excellos | 05-Nov-2021 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 0000 00000000 00.0 |
Carterra | 22-Dec-2020 | 00000 00000 | 00.000 | Discovery Tools (Healthcare) | Generating Revenue | 000000000 0000000 |
Magstim EGI | 02-Jul-2020 | Buyout/LBO | Diagnostic Equipment | Profitable | ||
Nivagen Pharmaceuticals | 19-May-2020 | Later Stage VC | 0000 | Pharmaceuticals | Generating Revenue | 000 0000 00 |
Telegraph Hill Partners Exits (31)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Verogen | 03-Jan-2023 | Merger/Acquisition | 00000 |
Specific | 18-May-2022 | 000000000000000000 | 00000 |
AltheaDx | 26-Apr-2022 | 000000000000000000 | 000.00 |
Agena Bioscience | 20-Oct-2021 | 000000000000000000 | 00000 |
Teknova | 25-Jun-2021 | 000 | 0000 |
Precision Nanosystems | 01-Jun-2021 | 000000000000000000 | |
Akoya Biosciences | 16-Apr-2021 | 000 | 00000 |
Asuragen | 06-Apr-2021 | 000000000000000000 | 00000 |
Verogen | 01-Jan-2020 | Secondary Transaction - Private | |
Conductiv (IT Consulting and Outsourcing) | 28-Oct-2019 | Merger/Acquisition | 000.00 |
Telegraph Hill Partners Investments by Industry, Year, and Region
Telegraph Hill Partners Team (15)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Jeanette Welsh JD | Partner, Chief Financial Officer & Chief Operating Officer | 0 | 0 | San Francisco, CA | |
Matthew Mackowski | Chairman & Managing Director | 0 | 0 | 0 | San Francisco, CA |
Thomas Raffin MD | Co-Founder, Senior Partner & Venture Partner | 00 | 0 | 0 | San Francisco, CA |
Gary Curtis | Venture Partner | 0 | 0 | 0 | San Francisco, CA |
Raymond Falci | Venture Partner | San Francisco, CA |
Telegraph Hill Partners Co-Investors (14)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Agilent Technologies | 1 | 0 |
![]() |
![]() |
|
Ballast Point Ventures | 0 | 0 |
![]() |
![]() |
|
Piper Sandler | 0 | 0 |
![]() |
![]() |
|
Revvity | 0 | 0 |
![]() |
![]() |
|
Roche Venture Fund | 0 | 0 |
![]() |
![]() |